Biological E's Corbevax has got emergency use authorisation, or EUA
A second COVID-19 vaccine for children and teens has received emergency use authorisation in India. Biological E Ltd's Corbevax has got EUA for adolescents between 12 and 18 years, the vaccine-maker said in a statement today.
Till now India has been administering Bharat Biotech's Covaxin to teens between 15 and 18 years old since January 3.
The EUA, short for emergency use authorisation, for Corbevax's restricted use in emergency among adults was cleared by the regulator Drugs Controller General of India in December 2019.
"BE received the approval for restricted use in an emergency situation in adolescents aged 12 to 18 years based on interim results (of the ongoing phase II/III clinical study)," Biological E said in the statement today.
